Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.modpat.2023.100356 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "her2-low
4
"her2-low breast
4
breast cancer
4
cancer incidence
4
incidence clinicopathologic
4
clinicopathologic features
4
features survival
4
survival outcomes
4
outcomes real-world
4
real-world data
4
Similar Publications
Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer" [Eur J Cancer 180 (2023) 184-185].
Eur J Cancer
March 2024
Department of Liver Surgery, Peking Union Medical College Hospital, China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address:
Corrigendum to "HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort" [Modern Pathology 36(4) 100087].
Mod Pathol
December 2023
Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.